[ad_1]
Boston, June 17, 2021 /PRNewswire/ – Artemis Capital Partners (“Artemis”), a BostonA private equity firm focused on working with differentiated industrial technology companies has successfully sold its portfolio company BioDot (the “Company”) to ATS Automation Tool Systems (TSX stock code:they).
Since its establishment in 1994, BioDot has become the undisputed leader in the development of automated, high-throughput, ultra-low volume liquid handling systems for mission-critical applications. With a unique patent portfolio in ultra-low volume distribution and novel applications, BioDot provides testing and manufacturing solutions to its customers worldwide. From R&D to high-throughput point-of-care testing and production, BioDot continues to innovate and cooperate in the end markets of biotechnology, diagnostics, industry, life sciences and medical equipment.
Since Artemis acquired the United States, BioDot has achieved substantial growth March 2020. In the past year, the company’s development in business strategy, technological innovation and market tailwind has promoted BioDot. The BioDot partnership is the latest example of Artemis using one of its core papers-laboratory automation and diagnostics. The success of BioDot must be combined with an improved strategy and a loyal team.
Peter HuntThe founder and managing partner of Artemis and the chairman of BioDot commented on the transaction: “We are very proud of the BioDot team and its growth over the past year. The team’s unwavering dedication to quality, customers and innovation makes BioDot is the leader in precise, ultra-low volume fluid distribution in the medical point and clinical diagnostic end markets. It has been a good partnership from the beginning.”
Anthony v LemoThe CEO of BioDot also expressed the same view: “Since the acquisition, our cooperation with the Artemis team has been critical to our strategic growth. We believe that we have laid a good foundation for the next chapter, and we feel very much about the results. Excited.”
Baird is a financial advisor, Morgan Lewis Served as legal counsel of Artemis.
About BioDot
BioDot was established in 1994 to produce high-quality non-contact quantitative fluid distribution systems. Combining its expertise in lamination, cutting, and assembly, its broad platform serves BioDot’s customers, from R&D to high-volume manufacturing in the industrial, diagnostic, life science and medical product markets.Based on Irvine, California, BioDot has international offices to provide services for various industries in each country. Its long-term relationship with customers is built on precision products and high-quality services from all over the world. Visit the company website: https://www.biodot.com more details.
About Artemis
Founded in 2010, Artemis is a BostonThe US-based private equity firm focuses on acquiring and developing differentiated industrial technology manufacturers, including analytical and laboratory instruments. Artemis seeks to cooperate with companies that have a strong and mature management team, outstanding engineering capabilities, unique products and an expanding niche market. For more information about Artemis, please visit: www.artemislp.com
View original content and download multimedia:http://www.prnewswire.com/news-releases/artemis-announces-sale-of-its-portfolio-company-biodot-to-ats-301314886.html
SOURCE Artemis Capital Partners
[ad_2]
Source link
